The Committee to Revise the U.S. Public Health Recommendations on
Opportunistic Infection Prophylaxis has proposed three changes:
- Mycobacterium avium prophylaxis is to be elevated from "should be
considered" to "high priority."
- Pneumovax vaccination is to be elevated from "should be
considered"
to "high priority."
- Fungal prophylaxis (with fluconazole in patients with CD4 counts <50
cells/mm3) is to be elevated from "not recommended" to "to be
considered."
- These changes are currently under review by the full committee and will be
published in the federal register for public comment prior to becoming
"official."
|
